Compare STVN & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STVN | MMED |
|---|---|---|
| Founded | 1949 | 1983 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 2021 | 2026 |
| Metric | STVN | MMED |
|---|---|---|
| Price | $16.11 | $12.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $25.67 | $22.56 |
| AVG Volume (30 Days) | 575.1K | ★ 829.2K |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.67 | $15.99 |
| Revenue Next Year | $9.99 | $10.00 |
| P/E Ratio | $27.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.89 | $12.69 |
| 52 Week High | $28.00 | $17.86 |
| Indicator | STVN | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 33.71 |
| Support Level | $13.58 | N/A |
| Resistance Level | $16.69 | $15.80 |
| Average True Range (ATR) | 0.75 | 0.89 |
| MACD | 0.22 | -0.10 |
| Stochastic Oscillator | 69.79 | 0.86 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.